Viewing Study NCT03861702


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-01-29 @ 7:44 AM
Study NCT ID: NCT03861702
Status: COMPLETED
Last Update Posted: 2025-04-18
First Post: 2019-02-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma:
Sponsor: Nelson Yee
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: BTCRC-GI15-067
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View